Skip to main content
Clinical Trials/NL-OMON51510
NL-OMON51510
Recruiting
N/A

An intervention study to improve therapeutic compliance in adult patients with eosinophilic esophagitis. - EoE compliance

Amsterdam UMC0 sites72 target enrollmentTBD

Overview

Phase
N/A
Intervention
Not specified
Conditions
allergic esophagitis
Sponsor
Amsterdam UMC
Enrollment
72
Status
Recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional

Investigators

Sponsor
Amsterdam UMC

Eligibility Criteria

Inclusion Criteria

  • \- Written informed consent
  • \- Male or female patient
  • \- Age \>18 years
  • \- Previous diagnosis of EoE, confirmed by histopathology, with the presence of
  • \>15 eosinophilic granulocytes per high power field (hpf) in esophageal biopsies
  • \- Current maintenance treatment for EoE with a PPI or swallowed topical
  • corticosteroids or about to start with these maintenance medications as decided
  • during regular clinical practice

Exclusion Criteria

  • \- Severe and clinically unstable concomitant disease that may interfere with
  • the subject\*s ability to participate in the study
  • \- Receive investigational treatment during the study
  • \- Dilation of esophagus required
  • \- Insufficient Dutch or English language skills to understand patient
  • information leaflets

Outcomes

Primary Outcomes

Not specified

Similar Trials